Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial

JAMA

Volumn 294, Issue 10, 2005, Pages 1215-1223

  Stone, Gregg W ^a   Ellis, Stephen G ^b   Cannon, Louis ^c   Mann, J Tift ^d   Greenberg, Joel D ^e   Spriggs, Douglas ^f   O'Shaughnessy, Charles D ^g   DeMaio, Samuel ^h   Hall, Patrick ⁱ   Popma, Jeffrey J ^j   Koglin, Joerg ^k   Russell, Mary E ^k  

^a NewYork Presbyterian Hospital   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Northern Michigan Regional Hospital   (United States)

^d WAKEMED HEALTH AND HOSPITALS   (United States)

^e Florida Heart Institute   (United States)

^f Morton Plant Hospital   (United States)

^g Elyria Memorial Hospital   (United States)

^h Austin AI   (United States)

ⁱ South Carolina Heart Center   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k BOSTON SCIENTIFIC CORPORATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; PLACEBO; POLYMER; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY HOSPITAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; DRUG TARGETING; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METAL IMPLANTATION; MULTICENTER STUDY; OBSERVATION; POPULATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SLOW RELEASE FORMULATION; UNIVERSITY HOSPITAL; AGED; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG DELIVERY SYSTEM; MIDDLE AGED; RADIOGRAPHY; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; POLYMERS; STENTS;

EID: 24644477492     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.10.1215     Document Type: Article

References (20)

1. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
3. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stent for coronary artery lesions. Circulation. 2003;108:788-794.
4. Stone GW, Ellis SG, Cox DA, et al. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-231.
5. Goodroe Healthcare Solutions LLC; Millennium Research Group. Marketing Analysis. Natick, Mass: Boston Scientific Corp; 2005.
6. Agostoni P, Biondi-Zoccai GG, Gasparini GL, et al. Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Eur Heart J. 2005;26:881-889.
7. Cutlip DE, Chauhan MS, Baim DS, et al. Clinical restenosis after coronary stenting: perspectives from multicenter trials. J Am Coll Cardiol. 2002;40:2082-2089.
8. Serruys P, Kay I, Disco C, Deshpande N, de Feyter P. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months. J Am Coll Cardiol. 1999;34:1067-1074.
9. Kastrati A, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 1997;30:1428-1436.
10. Mercado N, Boersma E, Wijns W, et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis. J Am Coll Cardiol. 2001;38:645-652.
11. Kasaoka S, Tobis J, Akiyama T, et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol. 1998;32:1630-1635.
12. Serruys PW, Foley DP, Suttorp MJ, et al. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. J Am Coll Cardiol. 2002;39:393-399.
13. van der Zwet PM, Reiber JH. A new approach for the quantification of complex lesion morphology: the gradient field transform; basic principles and validation results. J Am Coll Cardiol. 1994;24:216-224.
14. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872-1878.
15. Ardissino D, Cavallini C, Bramucci E, et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA. 2004;292:2727-2734.
16. Aliabadi D, Tilli FV, Bowers TR, et al. Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. Am J Cardiol. 1997;80:994-997.
17. Poerner TC, Kralev S, Voelker W, et al. Natural history of small and medium side branches after coronary stent implantation. Am Heart J. 2002;143:627-635.
18. Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet. 1998;352:673-681.
19. Serruys PW. Arterial Revascularization Therapies Study: part II of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. Late-breaking trial results presented at: Annual Scientific Sessions of the American College of Cardiology; March 6, 2005; Orlando, Fla.
20. Orlic D, Bonizzoni E, Stankovic G, et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and midterm results. J Am Coll Cardiol. 2004;43:1154-1160.